|
Pharmacokinetic Comparison of an Angiotensin II Receptor Antagonist, Telmisartan,
in Japanese and Western Hypertensive Patients Using Population Pharmacokinetic
Method
S. TATAMI, N. YAMAMURA, A. SARASHINA, C.-L. YONG,
T. IGARASHI and Y. TANIGAWARA
|
15 |
|
Relationship between Pharmacokinetic Parameters and Occurrence of Adverse Events
in Clinical Trials Performed in Europe and United States for an Angiotensin II
Receptor Antagonist, Telmisartan
S. TATAMI, A. SARASHINA, N. YAMAMURA, T. IGARASHI and Y. TANIGAWARA
|
24 |
|
Lipopolysaccharide Transport System across Colonic Epithelial Cells in Normal and
Infective Rat
M. TOMITA, R. OHKUBO, and M. HAYASHI
|
33 |
|
Decreased Expression of Glucose and Peptide Transporters in Rat Remnant Kidney
N. NAKAMURA, S. MASUDA, K. TAKAHASHI, H. SAITO, M. OKUDA and K. INUI
|
41 |
|
Transepithelial Permeation of Tolbutamide across the Human Intestinal Cell Line,
Caco-2
N. NISHIMURA, K. NAORA, T. UEMURA, H. HIRANO and K. IWAMOTO
|
48 |
Utility of Microtiter Plate Assays for Human Cytochrome P450 Inhibition Studies in
Drug Discovery: Application of Simple Method for Detecting Quasi-irreversible and
Irreversible Inhibitors
Y. NARITOMI, Y. TERAMURA, S. TERASHITA and A. KAGAYAMA
|
55 |
The
Effects of Emulsifying Agents on Disposition of Lipid-Soluble Drugs
Included in
Fat Emulsion
Y. SUZUKI, Y. MASUMITSU, K. OKUDAIRA and M. HAYASHI
|
62 |
Protective
Effect of Inactive Ingredients against Nephrotoxicity of Vancomycin
Hydrochloride in Rats
N. HODOSHIMA, Y. NAKANO, M. IZUMI, N. MITOMI, Y. NAKAMURA,
M. AOKI, A. GYOBU, S. SHIBASAKI, and T. KUROSAWA
|
68 |
Proapoptotic
Effect of a Dietary Supplement: Water Soluble Chitosan Activates Caspase-8
and Modulating Death Receptor Expression
H. TAKIMOTO, M. HASEGAWA, K. YAGI, T. NAKAMURA,
T. SAKAEDA and M. HIRAI
|
76 |